ISRCTN10001405
Active, not recruiting
未知
Prospective Evaluation of AI R&D tool for patient stratification - Trial for Renal immuno-oncology model Experimental Evaluation (PEAR-TREE)
Ourotech Limited (trading as Pear Bio)0 sites20 target enrollmentOctober 14, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients undergoing surgery for renal cell carcinoma
- Sponsor
- Ourotech Limited (trading as Pear Bio)
- Enrollment
- 20
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18 years old and over
- •2\. Patients with operable kidney cancer
- •3\. Able to give informed consent
- •4\. Able to give 40 ml of blood and surgical sample yields \>\= 0\.4 g of cancerous tissue
Exclusion Criteria
- •1\. Inoperable or metastatic kidney cancer
- •2\. Pre\-operative haemoglobin levels below 120g/l
- •3\. Patients who have already commenced chemotherapy, targeted therapy, immunotherapy or radiotherapy
- •4\. Recurrence of cancer from any other site than the kidney
- •5\. Any other disease or finding that renders the patient at high risk of treatment complications or interferes with obtaining informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Development and validation of the AI-based diagnosis system for pathological findings in invasive front of colorectal cancerColorectal cancerJPRN-UMIN000039011Tokyo Medical and Dental University450
Recruiting
Not Applicable
Assessment of Clinical Performance of an AI Program for Measuring Thoracic Aortic DiameterThoracic aortic aneurysmJPRN-UMIN000046568Juntendo University80
Recruiting
Not Applicable
Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)Breast CancerTriple Negative Breast CancerNCT06182306Ourotech, Inc.30
Completed
Not Applicable
An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical DoctorsIdiopathic Pulmonary FibrosisInterstitial Lung DiseaseRadiomicsNCT05784207Maastricht University145
Not yet recruiting
Not Applicable
Investigation of clinical application of an AI program to predict left ventricular systolic dysfunction from ECGCardiovascular diseaseJPRN-UMIN000050501The University of Tokyo Hospital600